-
We advised Verge HealthTech Fund on leading a EUR-2.8-million funding round for the UK-Estonian startup Lifeyear. The investment will support the launch of Lifeyear’s remote patient management platform, delivering at-home digital cardiovascular care at selected UK hospitals, GP practices and virtual wards. “Lifeyear’s combination of clinical rigour and scalable technology makes it stand out. As […]
-
The EU is taking steps to integrate AI into healthcare and research by directing efforts to establish centres of excellence. Additionally, a stronger focus is being put on strengthening the European Research Area and developing innovation-driven policies. In this newsletter, our Life Sciences & Healthcare team will spotlight key legislative changes in our region and […]
-
We are providing pro bono legal assistance to Evija Rača, who was incorrectly diagnosed with an oncological disease in 2020 and, as a result, received inappropriate treatment over an extended period of time. It was discovered that the diagnosis was inaccurate only in 2024. Section 16, Paragraph 5 of the Law on the Rights of […]
-
Recognised as among Europe’s most innovative law firms The Financial Times Innovative Lawyers report 2025 has once again included Sorainen among the most innovative law firms in Europe. This year, we ranked 41st, placing us among the top 50 law firms on the continent and making Sorainen the only firm from the Baltics included in […]
-
The number of litigations and disputes is increasing in the life sciences sector worldwide, including across Europe and our region. This trend is driven by regulatory reforms, patent complexities, and the establishment of the Unified Patent Court (UPC). This newsletter highlights the key litigation trends that the businesses should be aware of and that have […]
